Esco Global Strategies
Key Figures: Costa Rica medtech exports: $4.2B (2024) | Free zone CIT: 0% (8 yrs) + 50% (4 yrs) | CAFTA-DR: 0% U.S. duty | Labor: ~$4.50-7/hr all-in | 2-4 day transit (Pacific) / 5-7 day (East Coast)
Costa Rica Medical Device Manufacturing Under CAFTA-DR
Costa Rica is the largest medical device exporter in Central America and among the top five in Latin America. In 2024, Costa Rican medtech exports exceeded $4.2B, representing over 30% of the country’s total exports. Boston Scientific, Medtronic, Abbott, Baxter, and Stryker are among the 80+ medical device companies operating in Costa Rican free zones. Costa Rica entered CAFTA-DR in 2009, giving manufacturers duty-free U.S. market access for qualifying goods.
For U.S. medical device companies evaluating nearshore production in the CAFTA-DR framework, Costa Rica and Dominican Republic represent the two most mature options. Understanding the differences between them is essential for location decision-making.
Costa Rica vs. Dominican Republic: Medical Device Manufacturing Comparison
| Factor | Costa Rica | Dominican Republic |
|---|---|---|
| Corporate income tax (free zone) | 0% (8 yrs) + 50% rate (4 yrs) | 0% (15-20 yrs, no phase-out) |
| U.S. import duty (CAFTA-DR) | 0% | 0% |
| Labor (all-in/hr) | ~$4.50-7/hr | ~$2.50-3.40/hr (EGS est.) |
| Transit to U.S. East Coast | 5-7 days (via Panama Canal) | 2-4 days |
| Medtech workforce depth | Very deep (Class II/III, precision) | Deep (Class I/II, established) |
| Industrial lease (per m2/yr) | $85-130/m2 | $43-86/m2 |
| Tax exemption duration | 12 years (with phase-out) | 15-20 years (full period) |
Costa Rica’s Medtech Strengths
Workforce sophistication: Costa Rica’s medtech workforce has 25+ years of experience in Class II and Class III device manufacturing, precision engineering, and complex assembly. For catheter systems, electrosurgical devices, implantable components, and optical systems, Costa Rica’s technical workforce depth exceeds DR’s current capability — though DR is investing in this direction.
University ecosystem: Universidad de Costa Rica, TEC, and CENFOTEC graduate thousands of engineers and technicians annually. Many are employed in medtech. This talent pipeline supports R&D-adjacent activities, process engineering, and validation that requires engineering-level expertise.
Regulatory track record: Costa Rican medtech facilities have extensive FDA inspection history. Devices under PMA pathways, requiring more intensive FDA oversight, have established production history in Costa Rica. This de-risks the regulatory component for companies producing higher-complexity devices.
When DR Outperforms Costa Rica for Medtech
Dominican Republic offers clear advantages over Costa Rica for: (1) lower labor intensity operations where cost per unit is primary; (2) longer tax exemption duration (Law 8-90’s 15-20 year full exemption vs. Costa Rica’s 12-year phased model); (3) lower industrial real estate costs; and (4) shorter East Coast transit time. For Class I and lower-complexity Class II devices where labor cost is the dominant variable, DR’s total cost structure is more favorable.
FAQs
Can Costa Rican medtech companies expand to Dominican Republic?
Yes. Costa Rican medical device companies with established U.S. market position and FDA relationships can establish DR free zone subsidiaries as lower-cost production nodes for volume lines while retaining Costa Rica operations for complex or Class III products. CAFTA-DR covers both countries — a dual-country CAFTA-DR production strategy is operationally coherent.
Which medical device categories are most competitive in Costa Rica?
Costa Rica’s deepest capabilities are in cardiovascular devices, advanced surgical instruments, precision implantable components, and electrosurgical equipment — categories requiring engineering precision and complex process controls. Mass-market medical supplies, wound care, and lower-complexity Class II devices are more cost-competitive in DR.
Evaluating CAFTA-DR medtech production options? Get a free analysis. Request analysis